Given the benefits of rapid diffusion, favorable blood-brain barrier permeability and versatile administration routes, these small molecule compounds will be one of the important candidates of GLP-1RA
The dose-response relationship is not linear
It helps make red blood cells, keeps nerves healthy, and aids in DNA creation
It analyzes the latest scientific findings, potential mechanisms of action, and how these drugs compare to existing treatment options
How Wegovy Compares to Other GLP-1 Options in Michigan | Medication | Active ingredient | Monthly list price (2026) | Indication | |---|---|---|---| | Wegovy 2.4 mg | Semaglutide | $1,349 | Chronic weight management | | Ozempic 2 mg | Semaglutide | $935 | Type 2 diabetes (off-label for weight) | | Mounjaro 15 mg | Tirzepatide | $1,023 | Type 2 diabetes (off-label for weight) | | Zepbound 15 mg | Tirzepatide | $1,059 | Chronic weight management | | Saxenda | Liraglutide 3 mg | $1,415 | Chronic weight management | Ozempic and Mounjaro are approved for type 2 diabetes, not chronic weight management
PMID 35053663.
